Paediatric addendum to the guideline on clinical investigation of medicinal products for the treatment of pulmonary arterial hypertension

This document is a paediatric addendum to the guideline on the clinical investigation of medicinal products for the treatment of pulmonary arterial hypertension. It includes guidance on paediatric clinical medicine development, with highlights on differences from adult pulmonary arterial hypertension and points out paediatric specific issues.

Keywords: Pulmonary arterial hypertension (PAH), paediatric, persistent pulmonary hypertension of the newborn, congenital heart disease

Topics

How useful was this page?

Add your rating